← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 2012Last known activity
Aug 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (2)
- NCT06270680CollaboratorEarly Phase 1Aug 1, 2024
- NCT01513759Overall official - principal investigatorPhase 3May 1, 2012
Details
- Last known activity
- Aug 1, 2024